Evidence for a Rad18-independent frameshift mutagenesis pathway in human cell-free extracts.

PloS One
Régine Janel-BintzAgnès M Cordonnier

Abstract

Bypass of replication blocks by specialized DNA polymerases is crucial for cell survival but may promote mutagenesis and genome instability. To gain insight into mutagenic sub-pathways that coexist in mammalian cells, we examined N-2-acetylaminofluorene (AAF)-induced frameshift mutagenesis by means of SV40-based shuttle vectors containing a single adduct. We found that in mammalian cells, as previously observed in E. coli, modification of the third guanine of two target sequences, 5'-GGG-3' (3G) and 5'-GGCGCC-3' (NarI site), induces -1 and -2 frameshift mutations, respectively. Using an in vitro assay for translesion synthesis, we investigated the biochemical control of these events. We showed that Pol eta, but neither Pol iota nor Pol zeta, plays a major role in the frameshift bypass of the AAF adduct located in the 3G sequence. By complementing PCNA-depleted extracts with either a wild-type or a non-ubiquitinatable form of PCNA, we found that this Pol eta-mediated pathway requires Rad18 and ubiquitination of PCNA. In contrast, when the AAF adduct is located within the NarI site, TLS is only partially dependent upon Pol eta and Rad18, unravelling the existence of alternative pathways that concurrently bypass this lesion.

References

Jun 14, 1967·Journal of Molecular Biology·B Hirt
Jun 1, 1997·Chemical Research in Toxicology·R L Napolitano, R P Fuchs
Feb 18, 1999·Molecular and Cellular Biology·A M CordonnierR P Fuchs
Mar 14, 2000·The Journal of Biological Chemistry·F YuanZ Wang
Jun 17, 2000·The EMBO Journal·C MasutaniF Hanaoka
Jan 5, 2002·Proceedings of the National Academy of Sciences of the United States of America·Bernard C BroughtonAlan R Lehmann
Jul 12, 2002·The EMBO Journal·Anne Bresson, Robert P P Fuchs
Jun 15, 2005·Annual Review of Biochemistry·Satya PrakashLouise Prakash
Aug 3, 2007·DNA Repair·Valérie SchmutzAgnès M Cordonnier
Mar 7, 2008·Biochemistry·Nana Nikolaishvili-FeinbergMarila Cordeiro-Stone
Oct 24, 2008·Proceedings of the National Academy of Sciences of the United States of America·Yih-Wen ChenKai-Ming Chou
Oct 14, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jung-Hoon YoonSatya Prakash
Feb 18, 2010·Molecular Cell·Marzena BienkoIvan Dikic
Jul 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jung-Hoon YoonLouise Prakash
Jan 19, 2011·The Journal of Cell Biology·Thomas GöhlerAlan R Lehmann

❮ Previous
Next ❯

Citations

Nov 2, 2016·Chemical Research in Toxicology·Ashis K BasuArindam Bose

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis
transfections
transfection
ubiquitination

Software Mentioned

Image J
Imager
Phospho

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.